Prescription drug overdose statistics visually

Popular Science has a chart with US overdose deaths by drug: ...the rate of reported overdoses the U.S. more than doubled between 1999 and 2010. About half of those additional deaths are in the pharmaceuticals category, which the CDC has written about before. Nearly three-quarters of the pharmaceuticals deaths are opioid analgesics—prescription painkillers like OxyContin and … Continue reading Prescription drug overdose statistics visually

The benefits of harm reduction are not as obvious as they seem

Theodore Dalrymple points out the inconsistency in the British Medical Journal's vigorous advocacy for harm reduction where heroin is concerned and its squeamishness with harm reduction for nicotine. He pulls a passage from BMJ and inserts comments: What, then, does the BMJ, so much in favour of harm reduction for heroin addicts, say about harm reduction … Continue reading The benefits of harm reduction are not as obvious as they seem

Methadonia

When Methadonia was first released, there was quite a bit of hand wringing over whether the film inaccurately presented methadone maintenance treatment in a negative light. Cassie Rodenberg, at The White Noise, who has been spending time with and blogging about homeless addicts in the Bronx says [emphasis mine]: Some on the streets find methadone worse than an original heroin addiction, while … Continue reading Methadonia

Dead addicts don’t recover, but…

This has gotten a lot of press. There's naloxone distribution doubt this will reduce overdose deaths. However, some pretty important questions remain: What happens after the overdose? What services/interventions might have prevented the overdose in the first place? The article references placing defibrillators in public places. What happens after someone is saved by one of those defibrillators? … Continue reading Dead addicts don’t recover, but…

Lines are being drawn

  A major treatment provider, Caron, weighs in on Hazelden's adoption of buprenorphine maintenance treatment:   We use buprenorphine (Suboxone) to assist with the detoxification process from opioids and the length of time can vary depending on the patient’s progress and additional medical issues, such as chronic pain. However, unlike Hazelden’s goal as stated in … Continue reading Lines are being drawn

Another Reaction to Hazelden’s Adoption of Suboxone

Mark Willenbring, a former Director of the Treatment and Recovery Research Division of the National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health weighs in on Hazelden's embrace of Suboxone Hazelden's new approach is a seismic shift that is likely to move the entire industry in this direction. I told Marv that it was like … Continue reading Another Reaction to Hazelden’s Adoption of Suboxone